知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

5 条记录 (耗时 0.015 秒)

    METHOD AND APPARATUS FOR THE ALIGNMENT OF VEHICLES PRIOR TO WIRELESS CHARGING
    2.
    发明申请
    METHOD AND APPARATUS FOR THE ALIGNMENT OF VEHICLES PRIOR TO WIRELESS CHARGING 审中-公开

    公开(公告)号：US20180312071A1

    公开(公告)日：2018-11-01

    申请号：US16030036

    申请日：2018-07-09

    申请人： Bruce Richard Long ,  Andrew W. Daga ,  Francis J. McMahon

    发明人： Bruce Richard Long ,  Andrew W. Daga ,  Francis J. McMahon

    IPC分类号： B60L11/18 ,  B62D15/02

    摘要： A vehicle alignment system is adapted to align a vehicle with a wireless power induction coil for wireless charging through use of magnetic resonant induction. The system includes a transmission line disposed in the parking slot so as to guide the vehicle to the wireless power induction coil for charging. The transmission line leaks a signal having an operating frequency that is detected to align the vehicle left-right in the parking slot when the vehicle is aligned for charging by the wireless power induction coil. At least two vehicle mounted antennas mounted on opposite sides of transmission line when the vehicle is aligned in the parking slot detect the operating frequency from the transmission line, and signal processing circuitry detects a relative signal phase between signals detected by the antennas. The relative phase differences between the detected signals from the antennas are representative of alignment of the vehicle with respect to the wireless power induction coil and the parking slot.

    METHODS TO PREDICT THE OUTCOME OF TREATMENT WITH ANTIDEPRESSANT MEDICATION
    3.
    发明申请
    METHODS TO PREDICT THE OUTCOME OF TREATMENT WITH ANTIDEPRESSANT MEDICATION 有权
    用抗抑郁药物预防治疗结果的方法

    公开(公告)号：US20080233657A1

    公开(公告)日：2008-09-25

    申请号：US12051494

    申请日：2008-03-19

    申请人： Francis J. McMahon ,  Gonzalo E. Laje ,  Silvia Paddock ,  Husseini K. Manji ,  Alexander F. Wilson

    发明人： Francis J. McMahon ,  Gonzalo E. Laje ,  Silvia Paddock ,  Husseini K. Manji ,  Alexander F. Wilson

    IPC分类号： G01N33/50

    CPC分类号： C12Q1/6883 ,  C12Q2600/106 ,  C12Q2600/156 ,  Y10T436/143333

    摘要： The invention provides a method for determining the outcome of treatment with an antidepressant medication in a patient. In particular, the invention provides a method of screening patients to identify those patients with a decreased risk of non-response to treatment with antidepressant medication comprising: (a) obtaining a sample of genetic material from the patients, and (b) assaying the sample for the presence of a genotype in the patients which is associated with a decreased risk of non-response to treatment with antidepressant medication, wherein the genotype is characterized by a polymorphism in a HTR2A, GRIK4, BCL2, or a combination thereof.

    摘要翻译： 本发明提供了一种用于确定患者抗抑郁药物治疗结果的方法。 特别地，本发明提供了一种筛选患者以鉴定那些患有抗抑郁药物治疗不应答风险降低的患者的方法，包括：（a）从患者获得遗传物质样品，和（b）测定样品 用于在与抗抑郁药物治疗无反应风险降低相关的患者中存在基因型，其中所述基因型的特征在于HTR2A，GRIK4，BCL2或其组合中的多态性。

    METHODS TO IDENTIFY PATIENTS AT RISK OF DEVELOPING ADVERSE EVENTS DURING TREATMENT WITH ANTIDEPRESSANT MEDICATION
    4.
    发明申请
    METHODS TO IDENTIFY PATIENTS AT RISK OF DEVELOPING ADVERSE EVENTS DURING TREATMENT WITH ANTIDEPRESSANT MEDICATION 审中-公开
    鉴别患有抗逆药物治疗不良事件风险的患者的方法

    公开(公告)号：US20110118133A1

    公开(公告)日：2011-05-19

    申请号：US13015068

    申请日：2011-01-27

    申请人： Francis J. McMahon ,  Gonzalo E. Laje ,  Silvia Paddock ,  Husseini K. Manji ,  A. John Rush

    发明人： Francis J. McMahon ,  Gonzalo E. Laje ,  Silvia Paddock ,  Husseini K. Manji ,  A. John Rush

    IPC分类号： C40B30/00

    CPC分类号： C12Q1/6883 ,  C12Q2600/106 ,  C12Q2600/156

    摘要： The invention provides a method of screening patients to identify those patients more likely to exhibit an increased risk of treatment-emergent suicidal ideation comprising: (a) obtaining a sample of genetic material from the patients, and (b) assaying the sample for the presence of a genotype in the patients which is associated with an increased risk of treatment-emergent suicidal ideation, wherein the genotype is characterized by a polymorphism in a gene selected from the group consisting of glutamine receptor, ionotropic, kainate 2 (GRIK2); glutamate receptor ionotropic AMPA 3 (GRIA3); and combinations thereof.

    摘要翻译： 本发明提供了一种筛选患者的方法，以鉴定那些更有可能呈现出治疗出现的自杀意念增加的风险的患者，其包括：（a）从患者获得遗传物质样品，和（b）测定样品的存在 其中所述基因型的特征在于选自谷氨酰胺受体，离子型，红藻氨酸盐2（GRIK2）的基因的多态性。 谷氨酸受体离子型AMPA 3（GRIA3）; 及其组合。